fbpx

Verofax Raises $1.2 Million in Seed Funding

Verofax Raises $1.2 Million in Seed Funding

Verofax Limited, an automation and traceability platform, has secured $1.2 million in a Seed funding round, led by Trove Capital UK. Other investors included MFD Holding, Kepler Fund Managers, and Casablanca Holding.

This funding marks Verofax porting its platform on Microsoft Cloud and its recent expansion into Asia and Africa in Q4 2020.

Verofax was founded in 2018 and has since developed an automation and traceability platform that allows enterprises to prevent counterfeit, improve manufacturers’ engagement with consumers, and increase staff productivity with data insights.

Verofax offers services such as Item ID serialization, traceability, and transaction certification on private Blockchain with cost and time to market advantage.

Wassim Merheby, CEO and Co-Founder of Verofax commented on the round, “Counterfeit is exceeding 20% of global trade in some industries and accounts for $1.8T losses to businesses. With retailers and manufacturers adopting traceability and item serialization in their operations, Verofax enables supplier screening, consumer engagement, and inventory optimization.

“US, EU, China, and Russia have already adopted regulation for retailer and E-commerce accountability on fake merchandise sold through their marketplaces. Verofax simply adds certainty in global trade with item digital ID throughout every product lifecycle.”

The startup has established partnerships with a sustainable retailer in Asia, and set-up JVs in Asia, Africa, and the GCC. The startup has also been approved as a co-sell partner by Microsoft, Oracle, and AntGroup.

The Abu Dhabi based startup also has office in Kuala Lumpur. It plans to use the funding to serve its pipeline of projects, launch a marketing campaign targeted at food, healthcare, and apparel industries. It is also to hire 20 additional team members, mainly software developers and business development managers.

If you see something out of place or would like to contribute to this story, check out our Ethics and Policy section.